.Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX14_Gallium68gaGozetotide.Gallium68gaGozetotide .Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX14_Gallium68gaGozetotide.Gallium68gaGozetotide| name: | Gallium68gaGozetotide |
| ATC code: | V09IX14 | route: | intravenous |
| n-compartments | 1 |
Gallium (68Ga) gozetotide, also known as 68Ga-PSMA-11, is a radiopharmaceutical agent used in positron emission tomography (PET) imaging for the detection of prostate-specific membrane antigen (PSMA) expressing prostate cancer lesions. It is approved for diagnostic purposes in patients with prostate cancer and is not used for therapeutic applications.
Pharmacokinetic parameters in adult male patients with prostate cancer, healthy renal and hepatic function, following single intravenous administration for diagnostic PET imaging.
Inaki, A, et al., & Kinuya, S (2024). Evaluation of . Annals of nuclear medicine 38(8) 587–595. DOI:10.1007/s12149-024-01931-7 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38750331
Olde Heuvel, J, et al., & Stokkel, MPM (2021). Early differences in dynamic uptake of 68Ga-PSMA-11 in primary prostate cancer: A test-retest study. PloS one 16(2) e0246394–None. DOI:10.1371/journal.pone.0246394 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33529259